Prevalence of autoantibodies to the p53 protein in autoimmune hepatitis

Autoimmunity

Volumn 35, Issue 8, 2002, Pages 493-496

  Herkel, Johannes ^a   Modrow, Jan Philip ^a   Bamberger, Sonja ^a   Kanzler, Stephan ^a   Rotter, Varda ^b   Cohen, Irun R ^b   Lohse, Ansgar W ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

AIH; ANA; Autoimmunity; Hepatitis; Inflammation; p53

Indexed keywords

ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; AUTOANTIBODY; BILIRUBIN; HLA ANTIBODY; IMMUNOGLOBULIN; PROTEIN P53; PROTEIN P53 ANTIBODY; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE HEPATITIS; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS;

AUTOANTIBODIES; FEMALE; HEPATITIS, AUTOIMMUNE; HUMANS; MALE; MIDDLE AGED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0036932963     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/0891693021000054075     Document Type: Article

References (29)

1. Alvarez, F., Berg, P.A., Bianchi, P.B., Bianchi, L., Burroughs, A.K., Cancado, E.L., et al. (1999) "International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis", J. Hepatol. 31, 929-938.
2. Meyer Zum Büschenfelde, K.H., Lohse, A.W., Manns, M. and Poralla, T. (1990) "Autoimmunity and liver disease", Hepatology 12, 354-363.
3. McFarlane, I.G., Vergani, D. and Eddleston, A.L.W.F. (1998) "Pathogenesis of autoimmune hepatitis", In: Krawitt, E.L., Wiesner, R.H. and Nishioka, M., eds, Autoimmune Liver Diseases (Elsevier Science, Amsterdam), p. 35.
4. Offer, H., Milyavsky, M., Erez, N., Matas, D., Zurer, I., Harris, C.C. and Rotter, V. (2001) "Structural and functional involvement of p53 in BER in vitro and in vivo", Oncogene 20, 581-589.
5. Ko, L.J. and Prives, C. (1996) "p53: Puzzle and paradigm", Genes Dev. 10, 1054-1072.
6. Moll, U.M., LaQuaglia, M., Benard, J. and Riou, G. (1995) "Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors", Proc. Natl Acad. Sci. USA 92, 4407-4411.
7. Firestein, G.S., Nguyen, K., Aupperle, K.R., Yeo, M., Boyle, D.L. and Zvaifler, N.J. (1996) "Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium", Am. J. Pathol. 149, 2143-2151.
8. Maacke, H., Kessler, A., Schmiegel, W., Roeder, C., Vogel, I., Depert, W. and Kalthoff, H. (1997) "Overexpression of p53 protein during pancreatitis", Br. J. Cancer 75, 1501-1504.
9. Soussi, T. (2000) "p53 Antibodies in the sera of patients with various types of cancer: A review", Cancer Res. 60, 1777-1788.
10. Raedle, J., Oremek, G., Welker, M., Roth, W.K., Caspary, W.F. and Zeuzem, S. (1996) "p53 Autoantibodies in patients with pancreatitis and pancreatic carcinoma", Pancreas 13, 241-246.
11. Fricke, H., Urban, S., Noehl, N. and Folwaczny, C. (1998) "Serum p53 antibodies in patients with chronic inflammatory bowel disease", Gut 42, 899.
12. Kuhn, H.M., Kromminga, A., Flammann, H.T., Frey, M., Layer, P. and Arndt, R. (1999) "p53 Autoantibodies in patients with autoimmune diseases: A quantitative approach", Autoimmunity 31, 229-235.
13. Kovacs, B., Patel, A., Hershey, J.N., Dennis, G.J., Kirschfink, M. and Tsokos, G.C. (1997) "Antibodies against p53 in sera from patients with systemic lupus erythematosus and other rheumatic diseases", Arthritis Rheum. 40, 980-982.
14. Herkel, J., Mimran, A., Erez, N., Kam, N., Lohse, A.W., Marker-Hermann, E., Rotter, V. and Cohen, I.R. (2001) "Autoimmunity to the p53 protein is a feature of systemic lupus erythematosus (SLE) related to anti-DNA antibodies", J. Autoimmun. 17, 63-69.
15. Di Cesare, E., Previti, M., Lombardo, F., Di Benedetto, A., Mazzu, N., Romano, G., et al. (2001) "Serum anti-p53 autoantibodies in patients with type 1 diabetes", Ann. Clin. Lab. Sci. 31, 253-258.
16. Lubin, R., Schlichtholz, B., Bengoufa, D., Zalcman, G., Tredaniel, J., Hirsch, A., et al. (1993) "Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface", Cancer Res. 53, 5872-5876.
17. Livni, N., Eid, A., Ilan, Y., Rivkind, A., Rosenmann, E., Blendis, L.M., Shouval, D. and Galun, E. (1995) "p53 Expression in patients with cirrhosis with and without hepatocellular carcinoma", Cancer 75, 2420-2426.
18. Akyol, G., Dursun, A., Poyraz, A., Uluoglu, O., Ataoglu, O., Edaly, N. and Memis, L. (1999) "P53 and proliferating cell nuclear antigen (PCNA) expression in non-tumoral liver diseases", Pathol. Int. 49, 214-221.
19. Shohat-Foord, O., Bhattacharya, P., Reich, Z. and Rotter, V. (1991) "A DNA binding domain is contained in the C-terminus of wild type p53 protein", Nucl. Acids Res. 19, 5191-5198.
20. Herkel, J., Erez-Alon, N., Mimran, A., Wolkowicz, R., Harmelin, A., Ruiz, P., et al. (2000) "Systemic lupus erythematosus in mice, spontaneous and induced, is associated with autoimmunity to the C-terminal domain of p53 that recognizes damaged DNA", Eur. J. Immunol. 30, 977-984.
21. Kanzler, S., Lohr, H., Gerken, G., Galle, P.R. and Lohse, A.W. (2001) "Long-term management and prognosis of autoimmune hepatitis (AIH): A single center experience", Z. Gastroenterol. 39, 339-341, 344-338.
22. Park, S.Z., Nagorney, D.M. and Czaja, A.J. (2000) "Hepatocellular carcinoma in autoimmune hepatitis", Dig. Dis. Sci. 45, 1944-1948.
23. Arbuthnot, P., Capovilla, A. and Kew, M. (2000) "Putative role of hepatitis B virus X protein in hepatocarcinogenesis: Effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways", J. Gastroenterol. Hepatol. 15, 357-368.
24. Graham, A.M., Dollinger, M.M., Howie, S.E. and Harrison, D.J. (1998) "Bile duct cells in primary biliary cirrhosis are 'primed' for apoptosis", Eur. J. Gastroenterol. Hepatol. 10, 553-557.
25. Erez-Alon, N., Herkel, J., Wolkowicz, R., Ruiz, P.J., Waisman, A., Rotter, V. and Cohen, I.R. (1998) "Immunity to p53 induced by an idiotypic network of anti-p53 antibodies: Generation of sequence-specific anti-DNA antibodies and protection from tumor metastasis", Cancer Res. 58, 5447-5452.
26. Tsuchiya, K., Kiyosawa, K., Imai, H., Sodeyama, T. and Furuta, S. (1994) "Detection of anti-double and anti-single stranded DNA antibodies in chronic liver disease: Significance of anti-double stranded DNA antibody in autoimmune hepatitis", J. Gastroenterol. 29, 152-158.
27. Chou, M.J., Lee, S.L., Chen, T.Y. and Tsay, G.J. (1995) "Specificity of antinuclear antibodies in primary biliary cirrhosis", Ann. Rheum. Dis. 54, 148-151.
28. Czaja, A.J., Morshed, S.A., Parveen, S. and Nishioka, M. (1997) "Antibodies to single-stranded and double-stranded DNA in antinuclear antibody-positive type 1-autoimmune hepatitis", Hepatology 26, 567-572.
29. Peakman, M., Bevis, L., Mieli-Vergani, G., Mowat, A.P. and Vergani, D. (1989) "Double stranded DNA binding in autoimmune chronic active hepatitis and primary sclerosing cholangitis starting in childhood", Autoimmunity 3, 271-280.